View Older Stories View More Recent Stories

May 29, 2020 04:18PM Pfizer (PFE) Phase 3 PALLAS Trial of IBRANCE Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer Unlikely to Show Statistically Significant Improvement
May 29, 2020 04:15PM Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer
May 28, 2020 08:30AM Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging
May 28, 2020 08:30AM Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging
May 26, 2020 07:31AM ContraFect (CFRX) Announces Private Placement of Common Stock and Warrants to Pfizer
May 26, 2020 07:30AM ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc.
May 22, 2020 04:30PM Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC
May 18, 2020 09:24PM Pfizer Prices $4,000,000,000 Debt Offering
May 15, 2020 08:02AM Pfizer (PFE) Reports New Phase 1b Results of Gene Therapy in Ambulatory Boys with DMD Support Advancement into Pivotal Phase 3 Study
May 15, 2020 08:00AM Pfizer’s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study
May 14, 2020 10:01AM Pfizer (PFE) Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
May 14, 2020 10:00AM Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
May 13, 2020 10:00AM Save the Date: Pfizer Announces New Date of September 14, 2020 for Rescheduled Investor Day
May 12, 2020 12:00PM New Data from 18 Approved and Investigational Pfizer Medicines to be Showcased at ASCO20 Virtual Scientific Program
May 12, 2020 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
May 8, 2020 10:00AM Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting
May 5, 2020 06:45AM Pfizer (PFE), BioNTech (BNTX) Dose First Participants in U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
May 5, 2020 06:45AM Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
May 5, 2020 06:45AM Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
May 4, 2020 09:00AM New Data Suggest Burden of Group B Streptococcus (GBS) Infection in U.S. Adults Greater Than Previously Recognized
Apr 30, 2020 05:59AM Pfizer (PFE), Valneva Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
Apr 30, 2020 01:00AM Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
Apr 29, 2020 05:48AM Pfizer (PFE), BioTech (BNTX) Report Complete Patient Dosing in First Cohort of Ph. 1/2 Trial of COVID-19 vaccine candidates in Germany
Apr 29, 2020 03:42AM BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
Apr 29, 2020 03:42AM BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
Apr 23, 2020 01:54PM Pfizer Hosts Virtual-Only Annual Meeting of Shareholders
Apr 22, 2020 05:00AM BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
Apr 22, 2020 05:00AM BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
Apr 9, 2020 07:50AM Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Apr 9, 2020 07:50AM Pfizer Advances Battle Against COVID-19 on Multiple Fronts
Apr 9, 2020 07:39AM Pfizer (PFE) and BioNTech (BNTX) Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Apr 9, 2020 07:38AM Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Apr 9, 2020 07:37AM Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Apr 9, 2020 06:13AM Pfizer (PFE), EMD Serono Granted FDA Breakthrough Therapy Designation & Submit Application for BAVENCIO
Apr 9, 2020 06:00AM EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Apr 8, 2020 06:27PM U.S. FDA Approves BRAFTOVI® (Encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy
Apr 7, 2020 04:45PM Pfizer to Hold Virtual-Only 2020 Annual Meeting of Shareholders
Apr 6, 2020 08:00AM Pfizer and The Pfizer Foundation Donate $40 Million in Charitable Grants, Expand Product Access and Mobilize Colleagues to Combat COVID-19 Pandemic
Apr 2, 2020 02:05PM Pfizer (PFE) Receives European Approval for Oncology Biosimilar, RUXIENCE
Apr 2, 2020 02:04PM Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab)
Apr 2, 2020 09:09AM Pfizer (PFE) Reports Election of Susan Desmond-Hellmann to Board
Apr 2, 2020 09:00AM Susan Desmond-Hellmann Elected to Pfizer’s Board of Directors
Apr 1, 2020 04:00PM Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic
Apr 1, 2020 04:00PM Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic
Mar 27, 2020 10:20AM Pfizer Completes $1.25 Billion Sustainability Bond for Social and Environmental Impact
Mar 26, 2020 06:46AM Mylan (MYL), Pfizer (PFE) Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 26, 2020 06:45AM Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 26, 2020 06:45AM Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 24, 2020 06:51AM Pfizer (PFE) Announces U.S. FDA Approves sNDA for Expanded Indication of EUCRISA Ointment, 2% in AD
Mar 24, 2020 06:45AM U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of EUCRISA® (Crisaborole) Ointment, 2%, in Children as Young as 3 Months of Age With Mild-to-Moderate Atopic Dermati
View More Recent Stories View Older Stories